Evaluation Of Neda And Clinical Characteristics In Multiple Sclerosis Patients With High Serum Sema4a Levels

Akiko Namba,Tatsusada Okuno,Toru Koda,Kazuya Yamashita,Mikito Shimizu,Makoto Kinoshita,Atsushi Kumanogoh,Y. Miyazaki,Masaaki Niino,Katsuichi Miyamoto,Yuji Nakatsuji,Hideki Mochizuki

JOURNAL OF THE NEUROLOGICAL SCIENCES（2017）

引用 0|浏览14

暂无评分

摘要

Background: No Evidence of Disease Activity (NEDA) has become a new outcome measure in multiple sclerosis (MS). We previously reported that serum Sema4A was increased in approximately 30% of relapsing-remitting multiple sclerosis (RRMS) patients, and those who have high serum sema4A tended to have high EDSS score and didn’t respond well to interferon-β (IFN-β) therapy.

查看译文

关键词

multiple sclerosis patients,multiple sclerosis,neda

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要